Registry and biosample collection for cancer patients undergoing radiotherapy
Official title: Registry and Biosample Repository
Run by Abramson Cancer Center at Penn Medicine · NCT01577251 · Data updated 2026-11-12
This study is collecting blood, urine, and tumor samples from cancer patients receiving radiotherapy to see how the treatment affects them and to help improve future care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 8000 (estimated) |
| Sponsor | Abramson Cancer Center at Penn Medicine Academic / other |
| Locations | 4 sites (Moorestown, New Jersey and 3 other locations) |
| Status | Recruiting |
| Started | June 2008 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT01577251 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18 and older who have a diagnosis of cancer or a benign tumor and are undergoing radiotherapy.
✕Probably not a fit
Patients who are not undergoing radiotherapy or are under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create a comprehensive registry and biosample repository that includes blood, urine, and tumor specimens from patients diagnosed with cancer or benign tumors who are receiving radiotherapy. By collecting these samples, researchers hope to better understand the effects of radiotherapy and improve treatment outcomes. The study is observational, meaning it will gather data without intervening in the treatment process. Participants will be recruited from various cancer centers in New Jersey and Pennsylvania.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of radiotherapy effects and lead to improved treatment strategies for cancer patients.
How similar studies have gone: Other studies have successfully established similar registries and biosample repositories, indicating that this approach is both viable and beneficial for advancing cancer research.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy * Able to sign consent
Where it's running
-
Virtua Health & Wellness Center
Voorhees Township, New Jersey, United States Recruiting -
Lancaster General Hospital
Lancaster, Pennsylvania, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
Virtua Samson Cancer Center
Moorestown, New Jersey, United States Not yet recruiting
Study contacts
- Principal investigator: Jay Dorsey, MD, PhD — University of Pennsylvania
- Study coordinator: Project Manager
- Email: radonccru@pennmedicine.upenn.edu
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using REMS ultrasound to check bone density in children and teens with conditions that lower bone strength
This project will test whether REMS, a radiation-free ultrasound method, can measure bone mineral density in children and adolescents aged 5–18 who have conditions that weaken their bones.
-
ProTarget — Danish nationwide targeted cancer treatment based on genomic profiling
This study will try commercially available targeted cancer medicines chosen for adults with advanced cancer based on specific DNA or protein changes in their tumor.
-
Access to targeted cancer therapies based on tumor genetics
This study is testing if matching advanced cancer patients with targeted treatments based on their tumor genetics can improve their outcomes and make it easier for them to access these therapies.
-
Using trained dogs to detect tumors in suspected cancer patients
This study tests whether trained dogs can sniff out cancer in people who are suspected of having tumors before they get a formal diagnosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.